Please login to the form below

Not currently logged in

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

US says medicine ads should include list prices

US says medicine ads should include list prices

The measure is intended to create better incentives for lowering prices, which is one of the four pillars of President Trump’s blueprint for pricing controls introduced in May, along with ... The move ramps up pressure on the industry on an issue that

Latest news

More from news
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

  • Focus on the fundamentals Focus on the fundamentals

    Brexit, Trump becoming president and in France a movement that did not exist two years ago holding the parliamentary majority.

  • Pharma deals continue to slide Pharma deals continue to slide

    With the dysfunctional political system in the US it is hardly surprising that eight months following President Trump’s inauguration, the repeal of Obamacare has been dropped and the pricing and ... Similarly, the Euro is now around 10% stronger

  • US health reforms US health reforms

    One of the things I think industry is worried about is if Congress and the President can’t get a health bill passed, do they turn to drug pricing because that ... added. President Trump himself has frequently called for lower drug prices. “Once

  • Deal Watch - May 2017 Deal Watch - May 2017

    This analysis includes medtech as well as pharma and biotech. It is speculated that US companies are delaying M&A deals while they wait for President Trump to implement the tax ... In a situation where the Federal Reserve is signalling further increases

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...